CTR acquires contract research company

A+ Science becomes an integral part of CTR's wholly owned subsidiary CTC Clinical Trial Consultants. The merger will enable CTC to offer a complete pharmacovigilance package, including monitoring both during the clinical development of the product and after approval.

‍

Read the full CTR press release here.